In patients with ST-segment elevation myocardial infarction , bioactive stents were associated with lower rates of recurrent myocardial infarction compared to drug-eluting stents at 2-year follow-up ; yet , the rates of cardiac death and ischemia-driven target lesion revascularization were similar .